kidney disease
| 4 min read
Pharma deals, FDA review hurdles, and more led the news this week.
| 3 min read
Bristol Myers Squibb has initiated a phase 1 study of BMS-986506, a cereblon E3 ligase modulator jointly developed with Evotec, triggering a $10 million milestone.
| 5 min read
Pioneering transplants from pigs to humans could mark a turning point for organ replacement.
| 2 min read
The milestone marks meaningful progress toward developing new therapeutic options for Alport syndrome, with first-patient dosing expected in early 2026.
Available on Demand
Large-scale clinicogenomic data sheds light on the biology of rare kidney disorders and opens doors to new treatment possibilities.
| 5 min read
Animal and cell culture models have fallen short in kidney disease research. Kidney organoids may offer a better way forward.
| 8 min read
Inhibitors that target gut microbial enzymes are likely the key to treating a variety of cardiovascular diseases, some of which have no other cure.
| 4 min read
A collaboration of nephrologists and biochemists created the first structure of “megalin,” a critical protein in kidney and brain disorders.
| 3 min read
Scientists identified a DNA repair gene that may hold the key to treating chronic kidney disease.
| 2 min read
Findings showed that Previse could predict the onset of AKI up to 48 hours in advance of onset, sooner than the standard hospital systems like XGBoost AKI prediction model and the Sequential Organ Failure Assessment (SOFA).
